Continuous Subcutaneous Neostigmine in the Management of Severe Myasthenia Gravis.

BMJ
doi 10.1136/bmj.1.6170.1050
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy